1. Bangert CA, Costner MI. Methotrexate in dermatology. Dermatol Ther 2007;20(4): 216-28.
2. Milojević M. Citotoksična sredstva. U: Karadaglić Đ.Dermatologija. Beograd: Vojnoizdavački zavod; 2000. str. 2251-6.
3. Barker J, Horn EJ, Lebwohl M, Warren RB,Nast A, Rosenberg W, et al. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the
Monika Szkultecka-Debek, Mariola Drozd, Nina Kiepurska, Agnieszka Janowska, Piotr Paprzycki and Beata Paluchowska
1. Bates D.W. et al.: The cost of adverse drug events in hospitalized patients. JAMA, 277, 4, 1997.
2. Borovicka J.H. et al.: Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents. Arch Dermatol., 147, 12, 2011. doi: 10.1001/archdermatol.2011.719.
3. Classen D.C. et al: Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA, 277, 4, 1997.
4. Dubey A.K. et al.: Dermatological adverse drug
Puspanjuli Sahu, Saritha Mohanan, Carounanidy Udayshankar, Sankappa P. Sinhasan and Ramachandra V. Bhat
, Winkelmann RK. Dermatology. Berlin: Springer; 1991. p. 849-60.
5. Civeira F; International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173(1):55-68.
6. Linton MF, Fazio S. Class A scavenger receptors, macrophages and atherosclerosis. Curr Opin Lipidol. 2001;12(5):489-95.
7. Kruth HS. Lipid deposition in human tendon xanthoma.Am J Pathol. 1985;121(2):311-5.
8. Tall AR, Small DM, Lees RS. Interaction of collagen with the lipids of
1. Lalević-Vasić BM, Jovanović M. History of dermatology and venereology in Serbia - part IV/1: Dermatovenereology in Serbia from 1919-1945. Serb J Derm Venereol 2010;2(1):5-12.
2. Skup jugoslovenskih dermatologa i venerologa i osnivanje Jugoslovenskog dermatovenerološkog društva [Meeting of the Yugoslav dermatologists and venereologists and foundation of the Association of dermatovenereologists of Yugoslavia]. Srp Arh Celok Lek 1928;30(2):147-9. (Serbian).
3. Grzybowski A. Polish dermatology
1. Crissey JT, Parish LC, Holubar K. The historical atlas of dermatology and dermatologists. New York: The Parthenon Publishing group; 2002.
2. Katić R. Poreklo srpske srednjovekovne medicine. Posebna izdanja DXXXII (The origin of Serbian medieval medicine. Monograph DXXXII). Beograd: SANU; 1981.
3. Katić R. Srpska medicina od IX-XIX veka. Posebna izdanja CCCX (Serbian medicine from the IX-XIX century. Monograph CCCX). Beograd: SANU; 1967.
4. Katić RV, ed. Medicinski spisi
1. Cox NH. A literally blinded trial of palpation in dermatology diagnosis. J Am Acad Dermatol 2007;56:949-51.
2. Boulos KM. Map of dermatology: web image browser for differential diagnosis in dermatology. Indian J Dermatol Venereol Leprol 2006;72(1):72-4.
3. Janković A. Possibilities of teledermatology in marking clinical, dermoscopic and histologic diagnosis [dissertation]. Niš (Serbia): Medicinski fakultet; 2007.
4. Wallach D, Coste J, Tilles G, Taieb. The first images of
The seven years’ war (1912 - 1918) and epidemics of infectious diseases, led to a great loss of lives and medical corps of Serbia. As already stated, venereal and skin diseases were spreading in the postwar period that can be seen from medical reports of dermatovenereology institutions. They contain appropriate pathologies and some specific conditions under which they developed. In dermatovenereal pathology, venereal diseases were still dominating. In the outpatientClinic for Skin and Venereal Diseases, 10.000 patients were examined during the period from 1919 to 1921, venereal diseases accounted for 73.13%, whereas skin diseases accounted for 26.87% of all established diagnoses. A similar distribution existed at the territory of Serbia (Belgrade excluded) in 1931: venereal diseases accounted for 73.4%, and skin diseases for 26.6%; moreover, in Belgrade, the situation was even more drastic: venereal diseases accounted for 84.7%, and skin diseases for 15.3%. However, in the student population, the distribution was reversed: 43% and 57%, respectively. In regard to venereal diseases, in the series from 1919 to 1921, non-endemic syphilis was the most common disease, if serologically positive cases (latent syphilis) were added up to the clinically manifested cases. In the same series of patients, syphilis was staged as follows: syphilis I in 10%, syphilis II in 29.3%, syphilis III in 1.7%, tabes dorsalis in 0.8%, and latent syphilis in 56% of patients. In regions with endemic syphilis, from 1921 to 1925, the distribution was as follows: syphilis I in 4%, syphilis II in 49.8%, syphilis III in 18.3%, hereditary syphilis in 1.3%, and latent syphilis in 26.5% of patients. In patients suffering from gonorrhea, balanitis was found in 4.5%, and arthritis in 0.43% of cases. Generally, spreading of prostitution had a significant role, and its abolition was an important preventive action. In regard to skin diseases, in the above-mentioned series of patients, treated at the Outpatient Clinic for Skin andVenereal Diseases (1919 - 1921), scabies was the commonest skin disease (26.7%), eczemas were the second most common (21.8%), followed by pyococcal diseases (20.4%), while fungal diseases (4.5%) and skin tuberculosis (1.9%) were considerably less frequent.
This is the final report about the foundation of modern dermatovenereology in Serbia.
Ana Oliveira, Joana S.P. Devesa, Peter B. Hill, Vanessa Silva and Patrícia Poeta
azoles. Vet Microbiol 2011, 152, 161–164.
21. Kiss G., Radványi S., Szigeti G., Lukáts B., Nagy G.: New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa. J Small Anim Pract 1997, 38, 51–56.
22. Loeffler A., Linek M., Moodley A., Guardabassi L., Sung J.M., Winkler M., Weiss R., Lloyd D.H.: First report of multiresistant, mecA -positive Staphylococcus intermedius in Europe: 12 cases from a veterinary dermatology referral clinic in Germany. Vet Dermatol 2007, 18, 412–421.
23. Ludwig C., de Jong A., Moyaert H., El
1. Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, et al. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics. 2019;143(1):e20183475.
2. Darrow DH, Greene AK, Mancini AJ, Nopper AJ; Section on dermatology, Section on otolaryngology-head and neck surgery, and Section on plastic surgery. Diagnosis and management of infantile hemangioma. Pediatrics. 2015;136(4):e1060-104.
3. Munden A, Butschek R, Tom WL, Marshall JS, Poeltler DM, Krohne SE, et al. Prospective study of infantile